SI-Bone Inc (SIBN) Insider Sells $162,634.65 in Stock

SI-Bone Inc (NASDAQ:SIBN) insider Scott A. Yerby sold 10,133 shares of SI-Bone stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $16.05, for a total transaction of $162,634.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

SIBN stock traded down $0.01 during midday trading on Friday, hitting $15.93. The company’s stock had a trading volume of 74,053 shares, compared to its average volume of 105,595. The company has a quick ratio of 14.73, a current ratio of 13.06 and a debt-to-equity ratio of 0.47. SI-Bone Inc has a 52-week low of $14.08 and a 52-week high of $23.03. The stock has a market capitalization of $391.54 million and a PE ratio of -22.44.

SI-Bone (NASDAQ:SIBN) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.25) by ($0.13). The business had revenue of $14.99 million for the quarter. Analysts expect that SI-Bone Inc will post -1.45 EPS for the current fiscal year.

A number of hedge funds have recently modified their holdings of the business. Charles Schwab Investment Management Inc. boosted its position in SI-Bone by 1.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 47,058 shares of the company’s stock valued at $887,000 after buying an additional 790 shares during the period. Legal & General Group Plc purchased a new position in SI-Bone in the 4th quarter valued at approximately $27,000. Citigroup Inc. purchased a new position in SI-Bone in the 4th quarter valued at approximately $46,000. Strs Ohio purchased a new position in SI-Bone in the 4th quarter valued at approximately $48,000. Finally, New York State Common Retirement Fund purchased a new position in SI-Bone in the 1st quarter valued at approximately $51,000. 37.92% of the stock is owned by institutional investors.

Several research firms recently weighed in on SIBN. Zacks Investment Research upgraded shares of SI-Bone from a “sell” rating to a “hold” rating in a report on Saturday, January 26th. ValuEngine downgraded shares of SI-Bone from a “buy” rating to a “hold” rating in a report on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $24.75.

TRADEMARK VIOLATION WARNING: “SI-Bone Inc (SIBN) Insider Sells $162,634.65 in Stock” was reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.baseballdailydigest.com/news/2019/05/18/si-bone-inc-sibn-insider-sells-162634-65-in-stock.html.

About SI-Bone

SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

See Also: What is a back-end load?

Insider Buying and Selling by Quarter for SI-Bone (NASDAQ:SIBN)

Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.